Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - TOTAL EQUITY
Total Equity INMB - INmune Bio, Inc.
38.1 M
LAST VALUE
-31.05%
2 YEAR CAGR
18.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR